Author： Rappange David R.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.27, Iss.12, 2009-12, pp. : 1031-1044
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Loss of bodyweight reduces drug use, costs in obesity
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. :
Access to resources
Recommend
Obesity intervention "very effective" in reducing drug costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 618, 2010-01 ,pp. :
Migraine drug-specific coverage maximum lowers costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 428, 2003-01 ,pp. :
Obesity outranks smoking, alcohol abuse in terms of healthcare costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. :
Linking DM to other employee healthcare programmes saves costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 454, 2004-01 ,pp. :